https://www.qingmupharm.com/ is the website of Sichuan Qingmu Pharmaceutical Co., Ltd., a Chinese pharmaceutical company.
Qingmu is located in Meishan City, Sichuan Province, China. It is a wholly-owned subsidiary of Chengdu Easton Biopharmaceuticals Co., Ltd.
Qingmu specializes in the R&D and manufacturing of generic active pharmaceutical ingredients (APIs) and advanced intermediates. It provides these products for both human and veterinary use.
In addition to APIs, Qingmu also produces mRNA materials and offers contract development and manufacturing organization (CDMO)/contract manufacturing organization (CMO) services.
The company focuses on innovation and has established R&D platforms for areas like asymmetric synthesis, transition metal catalysis, microchannel production, and enzyme catalysis.
Qingmu emphasizes quality, health/safety, environmental protection and sustainability in its manufacturing processes.

On the website, Qingmu provides information about its products, services, facilities, R&D capabilities, news releases, and contact details. It markets itself as an innovation-driven pharmaceutical company.
The website is presented in both Chinese and English, showing Qingmu's efforts to engage an international audience and business partners.